UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV

Not Applicable

Recruiting

Conditions: HIV Infections
Hiv

Interventions: Other: Community Antiretroviral Therapy

First Posted Date: 2023-11-13

Last Posted Date: 2025-01-09

Lead Sponsor: University of Washington

Target Recruit Count: 2720

Registration Number: NCT06126913

Locations: 🇺🇬
Infectious Diseases Institute, Makerere University, Kampala, Uganda

Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth

Not Applicable

Recruiting

Conditions: Child Behavior
Child Maltreatment
Parenting
Parent-Child Relations

Interventions: Behavioral: Promoting First Relationships

First Posted Date: 2023-10-31

Last Posted Date: 2023-10-31

Lead Sponsor: University of Washington

Target Recruit Count: 357

Registration Number: NCT06109766

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Drug Excretion in Breast Milk

Phase 4

Recruiting

Conditions: OCT1
Lactation
BCRP
Drugs in Breast Milk
Postpartum
Mammary Drug Transporters

Interventions: Drug: Cimetidine 200 MG

First Posted Date: 2023-09-28

Last Posted Date: 2024-08-06

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT06056583

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma

Phase 2

Recruiting

Conditions: Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
Clinical Stage IV Merkel Cell Carcinoma AJCC v8
Merkel Cell Carcinoma

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Biological: Retifanlimab
Drug: Tuparstobart
Drug: Verzistobart

First Posted Date: 2023-09-28

Last Posted Date: 2024-03-20

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT06056895

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Repurposing Valsartan May Protect Against Pulmonary Hypertension

Phase 2

Recruiting

Conditions: Pulmonary Arterial Hypertension
Right Heart Failure
Pulmonary Vascular Disorder
Right Ventricular Dysfunction

Interventions: Drug: Placebo
Drug: Valsartan 40 mg

First Posted Date: 2023-09-25

Last Posted Date: 2024-03-15

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT06053580

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Digital Clinical Hypnosis for Chronic Pain Management

Not Applicable

Active, not recruiting

Conditions: Chronic Low-back Pain

Interventions: Behavioral: Hypnosis audio recordings

First Posted Date: 2023-09-22

Last Posted Date: 2024-04-02

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT06050083

Locations: 🇺🇸
University of Washington, School of Medicine, Seattle, Washington, United States

Enterics for Global Health (EFGH)

Recruiting

Conditions: Shigella
Child
Diarrhea

First Posted Date: 2023-09-21

Last Posted Date: 2024-10-07

Lead Sponsor: University of Washington

Target Recruit Count: 9800

Registration Number: NCT06047821

Locations: 🇰🇪
Akala Health Center, Siaya, Kenya
🇰🇪
Dienya Health Centre, Siaya, Kenya
🇰🇪
Siaya County Referral Hospital, Siaya, Kenya

and more 30 locations

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Not Applicable

Recruiting

Conditions: Upper Tract Urothelial Carcinoma
Bladder Cancer
Urothelial Carcinoma

Interventions: Other: Best Practice
Other: Exercise Intervention
Other: App-Based Intervention
Other: Wearable Activity Tracker
Other: Interview
Other: Physical Performance Testing
Other: Questionnaire Administration

First Posted Date: 2023-09-18

Last Posted Date: 2024-08-07

Lead Sponsor: University of Washington

Target Recruit Count: 128

Registration Number: NCT06040762

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings

Not Applicable

Completed

Conditions: IUD
Contraception

Interventions: Other: IUD self-removal guide

First Posted Date: 2023-09-18

Last Posted Date: 2023-09-18

Lead Sponsor: University of Washington

Target Recruit Count: 116

Registration Number: NCT06042556

Locations: 🇺🇸
Cedar River Clinics, Renton, Washington, United States

Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Phase 2

Recruiting

Conditions: Castration-Resistant Prostate Carcinoma
Metastatic Prostate Adenocarcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Bone Scan
Drug: Carboplatin
Procedure: Computed Tomography
Drug: Etoposide
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Drug: Testosterone Cypionate

First Posted Date: 2023-09-15

Last Posted Date: 2024-09-30

Lead Sponsor: University of Washington

Target Recruit Count: 46

Registration Number: NCT06039371

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy